Breakthroughs Blog

City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.

Mothers and daughters bond, fight cancer together

November 4, 2016 | Stephanie Smith

Laura Rodriguez was just 18, just starting college, when she dropped out to help out her mother, Mary Grace, whose breast cancer had returned after 7 years. Thirty-five years later, cancer would happen again — and in some ways, history would repeat itself.

Continue Reading

Lung cancer patient won't let disease 'steal the beauty of today'

June 23, 2016 | Stephanie Smith

A few years ago, before he was diagnosed with stage 4 lung cancer, City of Hope patient AJ Patel had a pronounced fear of cancer. Three years into targeted therapy for non small cell lung cancer he has lost that fear and found beauty from living in the moment.

Continue Reading

Lung cancer patient finds joy in the moment

April 26, 2016 | City of Hope

Lung cancer survivor Aasit J. Patel is a man transformed. The super-friendly litigation manager from Irvine brims with life-affirming words of wisdom like, “Enjoy what you have, each and every minute!” and “Life is all about having fun!”

Continue Reading

International women’s day: 7 women changing the world of cancer treatment

March 8, 2016 | City of Hope

At City of Hope, we’re proud to have some of the most talented and passionate women in the medical industry serving at every level of the organization. Here, we’ve spotlighted just a few of the many City of Hope physicians and scientists who are breaking exciting new ground in cancer research, treatment and care.

Continue Reading

Lung cancer 2016: New drugs, more screening point to a brighter new year

December 23, 2015 | Veronique de Turenne

After years of modest gains in the field of lung cancer, the leading cause of cancer-related deaths throughout the world, doctors and researchers say significant advances in treatment and screening practices point to very good news in 2016.

Continue Reading

What I learned: 6 questions for lung cancer patient Emily Bennett Taylor

November 24, 2015 | Denise Heady

Emily Bennett Taylor was getting ready to celebrate her second wedding anniversary with her college sweetheart in June of 2012 when she learned she had been diagnosed with Stage 4 lung cancer. Here, Emily answers questions about her diagnosis and treatment at City of Hope.

Continue Reading

Lung cancer survivor: What I learned during treatment

September 30, 2015 | Emily Taylor

Emily Taylor was 28 years old and about to celebrate two years of marriage with Miles, her college sweetheart, when a wheeze brought her to a doctor's office. A former athlete who had never smoked, Taylor was stunned when a scan revealed she had Stage 4 lung cancer.

Continue Reading

PRECISION MEDICINE: WHAT IT MEANS NOW. WHAT IT MEANS FOR THE FUTURE

August 25, 2015 | Veronique de Turenne

Welcome to the brave new world of precision medicine, in which the diseases themselves can point to a treatment and even a cure. What was once dismissed as futuristic has now become reality for some cancer patients, and with leading-edge research and groundbreaking partnerships, City of Hope stands in the precision medicine vanguard.

Continue Reading

The star of annual ASCO meeting? The human immune system

June 6, 2015 | Nicole Levine

Of the hundreds of important developments in cancer research and care showcased at one of the world’s largest medical meetings, featuring scores of studies about drugs, chemotherapy and radiation, the most exciting tool showcased for fighting cancer was the human immune system.

Continue Reading

NCI-MATCH: Trial focuses on mutations for rare cancers, not tumor site

June 2, 2015 | Nicole Levine

Precision medicine is becoming a reality for cancers with genetic mutations that are practically household names, such as those behind some breast cancers and lung cancers. A new multicenter trial focuses on providing precision treatments for rare cancers based on genetics, not tumor site.

Continue Reading

Load More
Back To Top